BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/03/2000

Sankyo Co., Ltd. Withdraws FDA Petition for GRAS Affirmation of Dextranase Enzyme

Sankyo Co., Ltd. has withdrawn its petition to the FDA, without reserving the right to refile, for affirmation that a specific enzyme preparation derived from Chaetomium gracile is generally recognized as safe (GRAS) for use in cane and beet sugar processing.

Source: Federal Register — Food and Drug AdministrationOpen original release →